MINI - SYMPOSIUM
Cancer Immunotherapy
November 4, 2026 • Zoom & In Person
2:00 PM IST
Amity Centre of Translational Research
Amity University - E2 Auditorium
Noida, Uttar Pradesh, India
Jointly Organized By:
SOUTH ASIA CHAPTER
Schedule
2:00 PM – 2:05 PM
Welcome Address & Introduction of Cancer Immunotherapy Unit
(CIU), Prof. (Dr) Hridayesh Prakash, Director CIU
2:05 PM - 2:10 PM- Address by Prof. (Dr) B. C. Das
Dean Health and Allied Science & Chairperson
Amity Institute of Molecular Medicine and Stem Cell Research, Amity University Noida
2:10 PM - 2:15 PM - Address by Prof. (Dr) Chanderdeep Tandon
Additional Pro VC and Dean FBB, Amity University Noida
5:00 PM – 5.30 PM - Dr. Vivek M. Rangnekar - GCC Founder
Markey Cancer Center, University of Kentucky, USA.
GCC Vision and Organizational Overview
2:15 PM – 3:00 PM Keynote Speaker - Prof. (Dr) Justin D. Lathia, Director
Cleveland Clinic, Cleveland, Ohio, USA
Title - Sex Differences in the Glioblastoma Immune Response
Neuro-Oncology Program
3:30 PM – 4:00 PM - Tea Break and Networking
3:00 PM – 3:30 PM - Dr. Jayanta Bhattacharya
IIT Delhi
Title – An Agonist-engineered Immunosome Overcomes Associated Toxicities and Provides Relapse-free Survival through Durable Anti-tumor Immunity.
4:00 PM - 4:30 PM - Dr. Sushma Agarwal
SGPGIMS, Lucknow
Title – Consolidation Radiotherapy in Oligo-Persistent Disease in Metastatic Non-Small Cell Lung Cancer Yields Encouraging Results
4:30 PM - 5:00 PM - Prof Manoj Garg
Amity Institute of Molecular Medicine and Stem Cell Research, NOIDA
Title – SNHG10 lncRNA Promotes Tumorigenesis in PDAC
5:30 PM – 5:45 PM Vote of Thanks, Dr. Monika Bhardwaj, Amity Centre for Translational Research
6:00 PM Departure